Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

ClinicalTrials.gov ID: NCT00603265

Public ClinicalTrials.gov record NCT00603265. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Multicenter Study to Assess the Safety and Efficacy of ADL5859 100 mg BID in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Study identification

NCT ID
NCT00603265
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Industry
Enrollment
226 participants

Conditions and interventions

Interventions

  • ADL5859 Drug
  • Duloxetine Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2007
Primary completion
Jul 31, 2008
Completion
Jul 31, 2008
Last update posted
Jun 30, 2015

2007 – 2008

United States locations

U.S. sites
27
U.S. states
14
U.S. cities
24
Facility City State ZIP Site status
Integrated Research Group Riverside California 92506
Torrance Clinical Research Torrance California 90505
FPA Clinical Research Kissimmee Florida 34741
Innovative Research of West Florida, Inc. Largo Florida 33770
Panhandle Family Care Associates & Emerald Coast Research Grp, Inc. Marianna Florida 32446
Renstar Medical Research Ocala Florida 34471
Radiant Research-St.Petersburg Pinellas Park Florida 33781
Doctor's Research Network South Miami Florida 33143
Metabolic Research Institute, Inc. West Palm Beach Florida 33401
Laszlo J. Mate, MD West Palm Beach Florida 33407
The Pain Treatment Center of the Bluegrass Lexington Kentucky 40503
Beacon Clinical Research Brockton Massachusetts 02301
Healthcare Research Florissant Missouri 63031
Creighton Diabetes Center, Creighton Univ. Sch. of Medicine Omaha Nebraska 68131
Advanced Biomedical Research of America Las Vegas Nevada 89123
Clnical Study Center of Asheville Asheville North Carolina 28801
Radiant Research-Akron Mogadore Ohio 44260
Neurology & Neuroscience Center of Ohio Toledo Ohio 43623
Aquilo Research Yukon Oklahoma 73099
Clinical Research Consultants, Research Department Medford Oregon 97504
Advanced Regional Center for Clinical Research (Ankle & Foot Care) Altoona Pennsylvania 16602
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Nerve & Muscle Center of Texas Houston Texas 77030
Invisions Consultants LLC San Antonio Texas 78217
Diabetes & Glandular Disease Research Associates San Antonio Texas 78229
S.A.M. Clinical Research Center San Antonio Texas 78229
Tidewater Integrated Medical Research Virginia Beach Virginia 23451

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00603265, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 30, 2015 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00603265 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →